Search

everythinglearnresearchcommunity

for

Search:↓

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

Finasteride and dutasteride can cause severe, lasting side effects.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

CL22209, an Asparagus racemosus extract, safely reduces perimenopausal symptoms and balances hormones.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

In post-menopausal women, signs of increased male hormones should be checked for possible ovarian cancer.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Ovarian stromal tumors are a rare cause of women developing male characteristics after menopause.

Higher testosterone and DHT levels are not linked to urinary symptoms in men.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

The paper suggests that a decrease in estrogen receptor activity may cause sexual dysfunction syndromes and proposes hormonal treatments.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

Benign conditions can mimic serious ones in postmenopausal hyperandrogenism, requiring careful diagnosis.

Clinicians need to better understand and treat Post-finasteride syndrome.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Kuntai capsules combined with nilestriol tablets effectively reduce perimenopausal symptoms and improve hormone levels.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Skin hormone levels change significantly after menopause.